Laparoscopic Sleeve Gastrectomy Short Term Follow up

NCT03465956 | Unknown DMC

• 1 other identifier: Mohamed gamal
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

Laparoscopic Sleeve Gastrectomy (LSG), Also known as longitudinal or vertical gastrectomy. LSG was initially considered a first-stage operation in high-risk patients before bilio-pancreatic diversion or Roux-en-Y gastric bypass surgery. However, LSG was subsequently found to be effective as a single procedure for treatment of morbid obesity.LSG functions mainly as a restrictive procedure in which about 75 % of the stomach is removed leaving a narrow gastric tube or sleeve. So, it limits the amount of food that can be eaten at one time via inducing early satiety after eating a small amount of food due to early distension of the fashioned gastric sleeve giving a sense of satiety, consequently losing excess body weight by time.Sleeve gastrectomy may also cause a decrease in appetite by reducing the amount of Ghrelin (hunger hormone) produced by the stomach.

Conditions

Morbid Obesity

Outcome Measures

Primary Outcomes (1)

• Assessment of excess weight loss

  Assessment of excess weight loss six months after the operation.

  First six months after surgery

Study Arms (1)

Laparoscopic Sleeve Gastrectomy

OTHER

Laparoscopic sleeve gastrectomy for patients with morbid obesity using the gastro-intestinal anastomosis stapler.

Procedure: Laparoscopic Sleeve Gastrectomy

Interventions

Laparoscopic Sleeve Gastrectomy PROCEDURE

Laparoscopic Sleeve Gastrectomy using the gastro-intestinal anastomosis stapler.

Laparoscopic Sleeve Gastrectomy

Eligibility Criteria

• Age: 20 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• All patients,males and females with age (20-50 years old) with morbid obesity (BMI ≥ 40 kg/m2 or \> 35 kg/m2 associated with co-morbidity), and are fit for laparoscopic surgery.

You may not qualify if:

• Patients having severe co-morbidity who are not fit for surgery or general anaesthesia.
• Patients with age below 20 years or above 50 years.

Sponsors & Collaborators

• Mohamed Gamal Thabet: lead
• Assiut University: collaborator

Study Sites (1)

AssiutU

Asyut, Egypt

RECRUITING

Related Publications (1)

• Nosso G, Angrisani L, Saldalamacchia G, Cutolo PP, Cotugno M, Lupoli R, Vitolo G, Capaldo B. Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes. 2011;2011:340867. doi: 10.1155/2011/340867. Epub 2011 Mar 8.

  PMID: 21423553 BACKGROUND

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

Obesity; Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Mohamed Gamal

  Assiut University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal investigator

Model Details: All patients,males and females with age (20-50 years old) with morbid obesity (BMI ≥ 40 kg/m2 or \> 35 kg/m2 associated with co-morbidity).

Study Record Dates

• First Submitted: February 21, 2018
• First Posted: March 15, 2018
• Study Start: April 1, 2018
• Primary Completion: March 1, 2020
• Study Completion: July 1, 2020
• Last Updated: March 20, 2018

Record last verified: 2018-03

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)